Claudia Stefanutti

4.3k total citations · 1 hit paper
98 papers, 2.2k citations indexed

About

Claudia Stefanutti is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claudia Stefanutti has authored 98 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 28 papers in Cardiology and Cardiovascular Medicine and 28 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claudia Stefanutti's work include Lipoproteins and Cardiovascular Health (70 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Lipid metabolism and disorders (22 papers). Claudia Stefanutti is often cited by papers focused on Lipoproteins and Cardiovascular Health (70 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Lipid metabolism and disorders (22 papers). Claudia Stefanutti collaborates with scholars based in Italy, United States and United Kingdom. Claudia Stefanutti's co-authors include S. Di Giacomo, Claudia Morozzi, Giancarlo Labbadia, A. Vivenzio, Daniel Gaudet, John J.P. Kastelein, Giovanni Battista Vigna, Maurizio Averna, LeAnne T. Bloedon and Dirk Blom and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Claudia Stefanutti

97 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

2012 524 citations Marina Cuchel, Emma A. Meagher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Stefanutti Italy	25	1.7k	689	667	439	276	98	2.2k
Kouji Kajinami Japan	27	1.4k 0.8×	424 0.6×	498 0.7×	462 1.1×	141 0.5×	82	2.3k
Marilyn Borgman United States	12	1.7k 1.0×	441 0.6×	508 0.8×	259 0.6×	343 1.2×	12	2.2k
М. В. Ежов Russia	17	1.3k 0.8×	431 0.6×	648 1.0×	350 0.8×	211 0.8×	154	1.8k
Lulu Ren Sterling United States	16	961 0.6×	368 0.5×	419 0.6×	247 0.6×	205 0.7×	21	2.2k
Kiyoko Uno United States	30	2.3k 1.4×	523 0.8×	1.1k 1.6×	263 0.6×	306 1.1×	70	3.3k
Norman E. Lepor United States	8	1.8k 1.1×	473 0.7×	460 0.7×	275 0.6×	656 2.4×	13	2.4k
Patrick M. Moriarty United States	18	1.3k 0.8×	349 0.5×	394 0.6×	282 0.6×	332 1.2×	40	1.7k
R.P. Naoumova United Kingdom	27	1.6k 0.9×	834 1.2×	556 0.8×	460 1.0×	145 0.5×	50	2.5k
Anja Vogt Germany	19	1.1k 0.7×	353 0.5×	397 0.6×	234 0.5×	296 1.1×	66	1.5k
G. Kees Hovingh Netherlands	30	2.1k 1.3×	1.3k 1.8×	1.0k 1.5×	646 1.5×	307 1.1×	76	3.4k

Countries citing papers authored by Claudia Stefanutti

Since Specialization

Citations

This map shows the geographic impact of Claudia Stefanutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Stefanutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Stefanutti more than expected).

Fields of papers citing papers by Claudia Stefanutti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Stefanutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Stefanutti. The network helps show where Claudia Stefanutti may publish in the future.

Co-authorship network of co-authors of Claudia Stefanutti

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Stefanutti. A scholar is included among the top collaborators of Claudia Stefanutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Stefanutti. Claudia Stefanutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Böck, Andreas, et al.. (2022). Lp(a) does not affect intima media thickness in hypercholesterolemic children –a retrospective cross sectional study. SHILAP Revista de lepidopterología. 51. 1–7. 2 indexed citations

Reeskamp, Laurens F., Susanne Greber‐Platzer, Samir Saheb, et al.. (2021). EVINACUMAB MARKEDLY REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN ADOLESCENT PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 77(18). 121–121. 1 indexed citations

Santos, Raúl D., Andrea Ruzza, G. Kees Hovingh, et al.. (2020). Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. New England Journal of Medicine. 383(14). 1317–1327. 115 indexed citations

Stefanutti, Claudia, Fernanda Pacella, S. Di Giacomo, et al.. (2019). Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis. Atherosclerosis Supplements. 40. 49–54. 14 indexed citations

Brunelli, Roberto, Giuseppina Perrone, Paola Galoppi, et al.. (2019). A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature. Atherosclerosis Supplements. 40. 117–121. 7 indexed citations

Stefanutti, Claudia & Maria Grazia Zenti. (2019). Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia. Current Pharmaceutical Design. 24(31). 3634–3637. 8 indexed citations

Hovingh, G. Kees, Frederick J. Raal, Ricardo Dent, et al.. (2017). Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia. Journal of clinical lipidology. 11(6). 1448–1457. 48 indexed citations

Kastelein, John J.P., Gisle Langslet, Paul N. Hopkins, et al.. (2016). EFFICACY OF ALIROCUMAB IN 1,191 PATIENTS WITH A WIDE SPECTRUM OF MUTATIONS IN GENES CAUSATIVE FOR FAMILIAL HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 67(13). 1864–1864. 1 indexed citations

Sjouke, Barbara, G. Kees Hovingh, John J.P. Kastelein, & Claudia Stefanutti. (2015). Homozygous autosomal dominant hypercholesterolaemia. Current Opinion in Lipidology. 26(3). 200–209. 42 indexed citations

10.

Stefanutti, Claudia & Gilbert R. Thompson. (2014). Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances. Current Atherosclerosis Reports. 17(1). 465–465. 48 indexed citations

11.

Cuchel, Marina, Dirk Blom, Maurizio Averna, et al.. (2013). Abstract 16516: Sustained LDL-C Lowering and Stable Hepatic Fat Levels in Patients With Homozygous Familial Hypercholesterolemia Treated With the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide: Results of an Ongoing Long-Term Extension Study. Circulation. 11 indexed citations

12.

Stefanutti, Claudia, et al.. (2013). Efficacy and Safety of Dif1stat ® for the Treatment of Secondary Dyslipidemia in Chronic Kidney Disease. IRIS Research product catalog (Sapienza University of Rome). 7(9). 941–949. 2 indexed citations

13.

Cuchel, Marina, Emma A. Meagher, Dirk Blom, et al.. (2012). Abstract 17396: Apheresis Treatment does not Affect the Lipid-Lowering Efficacy of Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Patients with Homozygous Familial Hypercholesterolemia. Circulation. 126. 3 indexed citations

14.

Stefanutti, Claudia, A. Vivenzio, S. Di Giacomo, & Pietro Ferraro. (2011). Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis. Cytokine. 55(2). 245–250. 28 indexed citations

15.

Stefanutti, Claudia, Claudia Morozzi, & Andrea Petta. (2011). Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia. Cytokine. 56(3). 842–849. 37 indexed citations

16.

Stefanutti, Claudia, et al.. (2009). Aorta and coronary angiographic follow‐up of children with severe hypercholesterolemia treated with low‐density lipoprotein apheresis. Transfusion. 49(7). 1461–1470. 24 indexed citations

17.

Stefanutti, Claudia, et al.. (2009). Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care. Transfusion and Apheresis Science. 42(1). 21–26. 28 indexed citations

18.

Stefanutti, Claudia, S. Di Giacomo, A. Vivenzio, et al.. (2009). Therapeutic Plasma Exchange in Patients With Severe Hypertriglyceridemia: A Multicenter Study. Artificial Organs. 33(12). 1096–1102. 58 indexed citations

19.

Stefanutti, Claudia, et al.. (2008). Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles. American Journal of Cardiovascular Drugs. 8(4). 265–270. 9 indexed citations

20.

Stefanutti, Claudia, et al.. (1998). Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.. PubMed. 149(2). 115–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact